Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2001-3-26
pubmed:databankReference
pubmed:abstractText
Deletions of the 13q14 chromosome region are associated with B-cell chronic lymphocytic leukemia (B-CLL) and several other types of cancer, suggesting the presence of a tumor suppressor gene. In previous studies the minimal region of deletion (MDR) was mapped to a less than 300-kilobase (kb) interval bordered by the markers 173a12-82 and 138G4/1.3R. For the identification of the putative tumor suppressor gene, the entire MDR (approximately 347 kb) has been sequenced, and transcribed regions have been identified by exon trapping, EST-based full-length complementary DNA cloning, database homology searches, and computer-assisted gene prediction analyses. The MDR contains 2 pseudogenes and 3 transcribed genes: CAR, encoding a putative RING-finger containing protein; 1B4/Leu2, generating noncoding transcripts; and EST70/Leu1, probably representing another noncoding gene (longest open reading frame of 78 codons). These genes have been sequenced in 20 B-CLL cases with 13q14 hemizygous deletion, and no mutations were found. Moreover, no somatic variants were found in the entire MDR analyzed for nucleotide substitutions by a combination of direct sequencing and fluorescence-assisted mismatch analysis in 5 B-CLL cases displaying 13q14-monoallelic deletion. The nondeleted allele of the CAR and EST70/Leu1 genes was expressed in B-CLL specimens, including those with monoallelic loss, whereas no expression of 1B4/Leu2 was detectable in B-CLL, regardless of the 13q14 status. These results indicate that allelic loss and mutation of a gene within the MDR is an unlikely pathogenetic mechanism for B-CLL. However, haplo-insufficiency of one of the identified genes may contribute to tumorigenesis. (Blood. 2001;97:2098-2104)
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
97
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2098-104
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:11264177-Animals, pubmed-meshheading:11264177-Base Sequence, pubmed-meshheading:11264177-Cell Transformation, Neoplastic, pubmed-meshheading:11264177-Chromosome Mapping, pubmed-meshheading:11264177-Chromosomes, Human, Pair 13, pubmed-meshheading:11264177-DNA, Complementary, pubmed-meshheading:11264177-DNA, Neoplasm, pubmed-meshheading:11264177-DNA Mutational Analysis, pubmed-meshheading:11264177-Expressed Sequence Tags, pubmed-meshheading:11264177-Gene Expression Regulation, Leukemic, pubmed-meshheading:11264177-Genes, Tumor Suppressor, pubmed-meshheading:11264177-Humans, pubmed-meshheading:11264177-Leukemia, Lymphocytic, Chronic, B-Cell, pubmed-meshheading:11264177-Mice, pubmed-meshheading:11264177-Molecular Sequence Data, pubmed-meshheading:11264177-Proteins, pubmed-meshheading:11264177-Pseudogenes, pubmed-meshheading:11264177-RNA, Messenger, pubmed-meshheading:11264177-RNA, Neoplasm, pubmed-meshheading:11264177-Sequence Deletion, pubmed-meshheading:11264177-Transcription, Genetic, pubmed-meshheading:11264177-Tumor Suppressor Proteins
pubmed:year
2001
pubmed:articleTitle
Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia.
pubmed:affiliation
Institute of Cancer Genetics, Columbia University, New York, New York 10032, USA.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't